Patents by Inventor Aaron Cowley

Aaron Cowley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES
    Publication number: 20220098247
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Application
    Filed: April 26, 2021
    Publication date: March 31, 2022
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth LINDNER, Helena COWLEY, Aaron COWLEY, Maria ÅKERMAN
  • Secretagogues derived from oxalobacter formigenes
    Patent number: 10988510
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: April 27, 2021
    Assignee: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth Lindner, Helena Cowley, Aaron Cowley, Maria Åkerman
  • SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES
    Publication number: 20190085035
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Application
    Filed: September 27, 2018
    Publication date: March 21, 2019
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth Lindner, Helena Cowley, Aaron Cowley, Maria Åkerman
  • Secretagogues derived from oxalobacter formigenes
    Patent number: 10125176
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: November 13, 2018
    Assignee: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth Lindner, Helena Cowley, Aaron Cowley, Maria Akerman
  • Methods and compositions for treating oxalate-related conditions
    Patent number: 9795657
    Abstract: The subject invention relates in one aspect to an oxalate degrading composition, which includes at least one oxalate degrading enzyme. The composition includes an enriched insoluble component of fungal bio sample, and the composition is effective to degrade oxalate at a pH of 1.9 or higher. The composition is protected from protease degradation such as pepsin, trypsin and chymotrypsin. The composition is capable of withstanding the conditions of the stomach, small intestines, and/or large intestines of a subject.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: October 24, 2017
    Assignee: CAPTOZYME, LLC
    Inventors: Aaron Cowley, Qing-Shan Li
  • SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES
    Publication number: 20160137701
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Application
    Filed: July 3, 2014
    Publication date: May 19, 2016
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth LINDNER, Helena COWLEY, Aaron COWLEY
  • Methods and Compositions for Treating Oxalate-Related Conditions
    Publication number: 20130108607
    Abstract: The subject invention relates in one aspect to an oxalate degrading composition, which includes at least one oxalate degrading enzyme. The composition includes an enriched insoluble component of fungal biosample, and the composition is effective to degrade oxalate at a pH of 1.9 or higher. The composition is protected from protease degradation such as pepsin, trypsin and chymotrypsin. The composition is capable of withstanding the conditions of the stomach, small intestines, and/or large intestines of a subject.
    Type: Application
    Filed: November 23, 2010
    Publication date: May 2, 2013
    Inventors: Aaron Cowley, Qing-Shan Li